A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
(Hinzugefügt: 22.12.2020 um 07:49 Uhr)
ADJUVANT AND OTHER EFFECTS OF BCG VACCINE AND ITS INFLUENCE ON THE EPIDEMIOLOGY OF NEW CORONAVIRUS DISEASE COVID-19
(Hinzugefügt: 07.12.2020 um 07:53 Uhr)
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers
(Hinzugefügt: 25.11.2020 um 21:31 Uhr)